Researchers are producing COVID-19 spike proteins to prevent future infections
On July 1, the Texas A&M Engineering Experiment Station's National Center for Therapeutics Manufacturing received funding from the National Institute for Innovation in Manufacturing Biopharmaceuticals to help find a way to prevent the SARS-CoV-2 virus from binding to cells, protecting people from future infections.
No hay comentarios:
Publicar un comentario